Rwanda launches Africa’s first trial of long-acting malaria injection
4 Articles
4 Articles
In Rwanda, the first study on an malaria injection starts. It could also protect pregnant women and should work for a whole year.
Rwanda launches Africa’s first trial of long-acting malaria injection
Rwanda has launched Africa’s first Phase 1b clinical trial of a potential long-acting injectable (LAI) designed to prevent malaria, marking a significant milestone in the development of new malaria prevention tools.Medicines for Malaria Venture (MMV) and Rinda Ubuzima, a leading Rwandan health research organisation, announced the commencement of the trial, which will evaluate a promising […]
New Malaria Prevention Injection Enters Clinical Trial in Rwanda - Rwanda Dispatch
Rwanda has begun a clinical trial of an experimental malaria-prevention injection designed to remain active in the body for months, in research that could expand the options available to prevent the disease if its safety and effectiveness are established. The Phase 1b trial of MMV371 was announced on November 2, 2026, by Medicines for Malaria […] The post New Malaria Prevention Injection Enters Clinical Trial in Rwanda appeared first on Rwanda D…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
